Fidelity CEO taps personal fortune for bets on cancer-related IPOs

April 9, 2015 4:41 PM

53 0

BOSTON, April 9 (Reuters) - Fidelity Investments Chief Executive Officer Abigail Johnson is betting part of her personal fortune on several companies developing cancer treatments, including three that have recently announced plans for initial public offerings.

In recent months, biopharmaceutical investments made on behalf of the 53-year-old billionaire and her siblings either have surged in value or have advanced further toward their stock market debuts.

Also read: Morgan Stanley positioned for Fed-fueled liftoff

Read more

To category page